The tariff classification of Doxazosin Mesylate (CAS-77883-43-3);Fluconazole (CAS-86386-73-4); Ciprofloxacin USP (CAS-85721-33-1); andFinasteride (CAS-98319-26-7), all in bulk form, from India
Reasoning
The tariff classification of Doxazosin Mesylate (CAS-77883-43-3);Fluconazole (CAS-86386-73-4); Ciprofloxacin USP (CAS-85721-33-1); andFinasteride (CAS-98319-26-7), all in bulk form, from India
Cite this ruling
CBP Ruling A89394 (2934903000): The tariff classification of Doxazosin Mesylate (CAS-77883-43-3);Fluconazole (CAS-86386-73-4); Ciprofloxacin USP (CAS-85721-33-1); andFinasteride (CAS-98319-26-7), all in bulk form, from India
Paste this into a product's override reason when citing this ruling as justification for a classification.
Other rulings for HS6 293490
The tariff classification of Fosinopril (CAS-90048-97-6); Lisinopril (CAS-83915-83-7); Nabumetone (CAS-42924-53-8); Paroxetine (CAS-61869-08-7); and Tramadol (CAS-27203-92-5), all imported in bulk form, from China
The tariff classification of 2-Chloronicotinic Acid (CAS 2942-59-8) from France.
The tariff classification of N-6-Benzoyl Adenosine from Switzerland
The tariff classification of 2-Mercaptobenzoxazole (CAS 2382-96-9) from France.
The tariff classification of Leflunomide (CAS-75706-12-6), imported in bulk form, from India, and Raloxifene Hydrochloride (CAS-82640-04-8), imported in bulk form, from Italy